Article

CIBA Vision opens Singapore production facility

Singapore—CIBA Vision has opened a multi-million-dollar contact lens and lens care manufacturing facility at Tulas Biomedical Park here, where it will employ 220 people now and 500 in the future.

Singapore-CIBA Vision has opened a multi-million-dollar contact lens and lens care manufacturing facility at Tulas Biomedical Park here, where it will employ 220 people now and 500 in the future.

The company has invested $85 million of the total $250 million it plans to spend on the project.

Mike Dilworth, vice president, global supply chain, for CIBA Vision, said the plant will serve as the company's Asia-Pacific supply chain hub for the global market and serve as a warehouse and distribution center for manufacturing activities in the region. It will supply Focus Dailies daily disposable soft contact lenses to the Asian market and O2OPTIX, produced in Batam, for the global market.

In other news, CIBA Vision appointed George Minno, PhD, as global head of lens care research and development. Dr. Minno will be responsible for bringing new lens care solutions to development. He joins the company from Alimera Sciences Inc., where he was vice president of product development, and he previously worked for CIBA Vision and Novartis Ophthalmics in technical and marketing positions.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.